- Home
- SHOO vs LGND Comparison
SHOO vs LGND Comparison
Compare SHOO & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOO
- LGND
- Stock Information
- Founded
- SHOO 1990
- LGND 1987
- Country
- SHOO United States
- LGND United States
- Employees
- SHOO N/A
- LGND 68
- Industry
- SHOO Shoe Manufacturing
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- SHOO Consumer Discretionary
- LGND Health Care
- Exchange
- SHOO Nasdaq
- LGND Nasdaq
- Market Cap
- SHOO 2.0B
- LGND 2.2B
- IPO Year
- SHOO 1993
- LGND 1992
- Fundamental
- Price
- SHOO $27.01
- LGND $151.08
- Analyst Decision
- SHOO Hold
- LGND Strong Buy
- Analyst Count
- SHOO 7
- LGND 8
- Target Price
- SHOO $27.83
- LGND $144.71
- AVG Volume (30 Days)
- SHOO 1.8M
- LGND 139.7K
- Earning Date
- SHOO 07-30-2025
- LGND 08-05-2025
- Dividend Yield
- SHOO 3.11%
- LGND N/A
- EPS Growth
- SHOO N/A
- LGND N/A
- EPS
- SHOO 1.28
- LGND N/A
- Revenue
- SHOO $2,319,527,000.00
- LGND $181,488,000.00
- Revenue This Year
- SHOO $13.01
- LGND $18.41
- Revenue Next Year
- SHOO $9.15
- LGND $18.87
- P/E Ratio
- SHOO $21.17
- LGND N/A
- Revenue Growth
- SHOO 7.97
- LGND 53.40
- 52 Week Low
- SHOO $19.05
- LGND $81.74
- 52 Week High
- SHOO $50.01
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- SHOO 57.34
- LGND 65.27
- Support Level
- SHOO $24.51
- LGND $137.14
- Resistance Level
- SHOO $27.44
- LGND $157.54
- Average True Range (ATR)
- SHOO 1.06
- LGND 6.22
- MACD
- SHOO 0.16
- LGND 0.92
- Stochastic Oscillator
- SHOO 91.70
- LGND 76.92
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.